Description

Specifications

• Form: White lyophilized powder, quad-peptide blend
• Standard vial size: 80mg total (10mg BPC-157 / 10mg TB-500 / 50mg GHK-Cu / 10mg KPV)
• Purity: ≥99% each peptide (HPLC & Mass Spec verified)
• Storage: Store lyophilized powder at -20°C; refrigerate at 2–8°C once reconstituted

Overview

KLOW extends the GLOW blend with the addition of KPV, an anti-inflammatory tripeptide, giving researchers a four-peptide protocol spanning angiogenesis, cell migration, dermal matrix remodeling, and inflammatory-pathway modulation in one formulation.

Mechanism & Research Findings

By layering KPV’s NF-κB-mediated anti-inflammatory signaling onto the BPC-157/TB-500/GHK-Cu repair triad, this blend is studied as a model for whether dampening local inflammatory signaling alongside pro-repair and pro-regenerative pathways produces measurable synergy in tissue-injury research models. It is one of the more complex standardized combination blends used in comparative multi-peptide protocol research.

Research Applications

• Combined anti-inflammatory + tissue-repair pathway research
• Four-peptide synergy and interaction studies
• Comparative multi-target vs. single-target protocol research

For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.